Canadian Respiratory Journal / 2019 / Article / Tab 1

Research Article

Concomitant Interstitial Lung Disease with Psoriasis

Table 1

Patient characteristics.

Overall n = 21 median (range) n (%)

 Age (years)66 (46, 86)
 Male14 (66.7)
 Body mass index (kg/m2)28.9 (20.8, 34.5)
 Smoking15 (71.4)
 Home oxygen therapy5 (23.8)
 Time from diagnosis of ILD (months)27 (0, 36)
 Time from diagnosis of psoriasis (years)2 (1, 45)
 Family history of psoriasis1 (4.8)
 PH or possible PH9 (42.9)
 Gastroesophageal reflux10 (47.6)
 NYHA functional class I/II/III/IV5/14/2/0
Pulmonary function test, % predicted
 FVC69 (38, 89)
 FEV1.0/FVC80 (71, 104)
 DLco47 (17, 95)
 FEV1.073 (42, 95)
6-minute walking test (m)280 (104, 579)
Lung biopsy5 (23.8)

ILD: interstitial lung disease; NYHA: New York Heart Association; PH: pulmonary hypertension.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.